IP Library Granted Patent US 12,297,483
Granted Patent B2
US 12,297,483 · App. 17/485,813 · Granted May 13, 2025

Compounds and methods relating to lysosomal storage disorders

Inventors: Alexander Cherkassky (Wayland, MA); Jason Cournoyer (Jamaica Plain, MA); Michael Gelb (Seattle, WA)
Assignees: Revvity Health Sciences, Inc.; University of Washington through its Center for Commercialization
C12Q1/34C07C233/18C07H15/10G01N2333/924
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,297,483
App. No.
17/485,813
Granted
May 13, 2025
Kind
B2
Abstract

Provided are molecules and methods for detecting enzymatic activity of various lysosomal storage enzymes. The molecules may be used as internal standards that may be combined with substrates that have improved solubility.

Claims (13)

1. A molecule comprising the formula:

where B1 is selected from the group consisting of: a methylene or an unsubstituted C 6 aryl;

B2 is a C 2 -C 7 chain comprising an amido, a urethane, an ester, a uriedo, a carbmamato, or a carbonyl bond to said molecule, wherein said C 2 -C 7 is unsubstituted, or wherein when said C 2 -C 7 comprises an alkyl or alkenyl chain, said B2 is unsubstituted or comprises a heteroatom or a substituent of N, O, or S, and wherein when said B2 is bonded by an amido, that said B2 is a C 3 , C 5 , or C 7 amido; and

B3 is selected from the group consisting of: an unsubstituted C 1 -C 20 alkyl, a heteroatom containing C 1 -C 20 alkyl; a C 1 -C 20 alkyl substituted with N, O, or S; an C 2 -C 20 alkenyl; a heteroatom containing C 2 -C 20 alkenyl; an C 2 -C 20 alkenyl substituted N, O, or S; an unsubstituted C 2 -C 20 alkynyl; a heteroatom containing C 2 -C 20 alkynyl; a C 2 -C 20 alkynyl having substitution of N, O, or S; an C 6 -C 20 aryl; and an C 6 -C 20 heterocyclic containing a heteroatom of N, O or S;

the molecule comprising a label, the label comprising a stable isotope of an element on said B2 or B3.

2. The molecule of claim 1 , wherein said stable isotope is selected from the group consisting of 2 H, 13 C, 15 N, 17 O, 18 O, 31 P and 34 S.

3. The molecule of claim 1 , wherein B1 is a methylene.

4. The molecule of claim 1 , where B2 is a C 3 amido, a C 5 amido, or a C 7 amido.

5. The molecule of claim 1 , wherein B3 is a C 2 -C 20 alkenyl having a substituent of N, O, or S.

6. The molecule of claim 1 , wherein: B1 is a methylene; B2 is a C 3 amido, a C 5 amido, or a C 7 amido; and B3 is a C 2 -C 20 alkenyl having a substituent of N, O, or S.

7. The molecule of claim 1 comprising:

8. The molecule of claim 1 , wherein said stable isotope is present on said B2.

9. The molecule of claim 8 , wherein said stable isotope is present on a terminal carbon, α-carbon, or a combination thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2026
From: GELB, MICHAEL
To: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Reel/Frame 074022/0617 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2026
From: CHERKASSKY, ALEXANDER; COURNOYER, JASON
To: PERKINELMER HEALTH SCIENCES, INC.
Reel/Frame 074024/0844 →
CHANGE OF NAME Recorded Mar 25, 2024
From: PERKINELMER HEALTH SCIENCES, INC.
To: REVVITY HEALTH SCIENCES, INC.
Reel/Frame 067006/0297 →